Pressmeddelande -

Derivatives: Adjustment in Active Biotech due to rights issue (21/08)

Active Biotech AB's (Active Biotech ) Annual General Meeting approved the proposed rights issue (1:12), whereby shareholders are entitled to one new share for every twelfth shares held. The subscription price is set at SEK 40. The record date is May 20, 2008. OMX Derivatives Markets has carried out a re-calculation of options and futures in Active Biotech.




  • Ekonomi, finans